C07K 16/3053
Skin, nerves, brain
Official title: {Skin, nerves, brain}
C07K16/3053 (Skin, nerves, brain) appears on 538 US grants and 905 published applications in this corpus.
Search patents in C07K- Granted patents
- 538
- Published applications
- 905
- Assignees
- 315
- Inventors
- 1,266
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 5 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 6 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 6 | 0 |
| 2002 | 2 | 13 |
| 2003 | 1 | 142 |
| 2004 | 1 | 6 |
| 2005 | 3 | 16 |
| 2006 | 6 | 8 |
| 2007 | 50 | 9 |
| 2008 | 22 | 7 |
| 2009 | 7 | 14 |
| 2010 | 7 | 18 |
| 2011 | 12 | 22 |
| 2012 | 11 | 23 |
| 2013 | 21 | 28 |
| 2014 | 15 | 34 |
| 2015 | 16 | 33 |
| 2016 | 27 | 68 |
| 2017 | 33 | 87 |
| 2018 | 39 | 48 |
| 2019 | 48 | 52 |
| 2020 | 42 | 56 |
| 2021 | 30 | 46 |
| 2022 | 26 | 43 |
| 2023 | 23 | 35 |
| 2024 | 19 | 35 |
| 2025 | 24 | 33 |
| 2026 | 9 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibodies targeting glioblastoma stem-like cells and methods of use thereof22 Sep 2026US 12,742,019 B2Wisconsin Alumni Research Foundation
- Humanized antibody targeting the tumor associated antigen IL13Ra211 Aug 2026US 12,703,750 B2Northwestern University
- PRAME TCR receptors and uses thereof19 May 2026US 12,630,607 B2BioNTech SE
- Glypican-2-binding moieties, chimeric antigen receptors and uses thereof21 Apr 2026US 12,606,635 B2Nanjing Legend Biotech Co., Ltd.
- T cell receptors and methods of use thereof17 Mar 2026US 12,577,287 B2University Health Network
- Humanized antibody targeting the tumor associated antigen il13ra21 Oct 2026US 2026/0297204 A1Northwestern University
- Novel tumor antigens for melanoma and uses thereof24 Sep 2026US 2026/0284166 A1Universite de Montreal
- Bispecific t cell activating antigen binding molecules10 Sep 2026US 2026/0265377 A1Hoffmann-La Roche Inc.
- TCR Specifically Recognizing Prame Antigen, and Co-Expressing Same with CD8 for Redirecting CD4 T Cells3 Sep 2026US 2026/0256915 A1Neowise Biotechnology Co., Ltd.
- Melanoma targeting human antibodies and therapeutic uses thereof27 Aug 2026US 2026/0250415 A1Istituto Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" - Irst S.R.L.
Most cited
By later US patents
- Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity604US 6,602,684 B1GlycArt Biotechnology AG · 2003
- Anti-cancer drugs for the treatment of melanomas and method for preparing thereof173US 4,414,148 ASanofi · 1983
- Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor113US 9,394,368 B2Novartis AG · 2016
- Methods of treating acute myeloid leukemia by blocking CD4775US 8,562,997 B2The Board of Trustees of the Leland Stanford Junior University · 2013
- Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity57US 7,517,670 B2GlycArt Biotechnology AG · 2009